- Latest week
- 17 Jul 2026
- Close
- 0.014000
- Fair value
- 0.133885
- Next-week expectancy
- Negative 27.93%
BLRX Chart Pack
BioLineRx Ltd.
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, BLRX was broadly unchanged, moving from 0.01 to 0.01. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -29.01 and has improved across the 12-week window. Market Dynamics is 1.21 on the latest week. Next-week expectancy is negative at 27.93% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 0.01
- 12-Week Change
- 0.00%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 27.93%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -29.01
- Market Dynamics
- 1.21
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 0.01
- 12-Week Change
- 0.00%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 27.93%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -29.01
- Market Dynamics
- 1.21
Over the latest 12 completed weeks ending 2026-07-17, BLRX was broadly unchanged, moving from 0.01 to 0.01. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -29.01 and has improved across the 12-week window. Market Dynamics is 1.21 on the latest week. Next-week expectancy is negative at 27.93% based on similar historical setup states.
Industry Peers
Israel equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| EVGN Evogene Ltd. | TLV | 17 Jul 2026 | 1.50 | 1.75 | 1.35 | 1.73 | 15.00% |
| BOLT BioLight Life Sciences Ltd. | TLV | 17 Jul 2026 | 3.69 | 4.14 | 3.69 | 4.07 | 10.25% |
| PLUR Pluri Inc. | TLV | 17 Jul 2026 | 5.30 | 5.95 | 4.85 | 5.70 | 7.51% |
| GFC-M G.F.C Green Fields Capital Ltd. | TLV | 3 Jul 2026 | 16.03 | 16.03 | 16.03 | 16.03 | 0.00% |
| HDST-M HBL - Hadasit Bio-Holdings Ltd | TLV | 17 Jul 2026 | 0.72 | 0.72 | 0.72 | 0.72 | 0.00% |
| PPBT Purple Biotech Ltd | TLV | 17 Jul 2026 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00% |
| XTLB XTL Biopharmaceuticals Ltd. | TLV | 17 Jul 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00% |
| ORMP Oramed Pharmaceuticals Inc. | TLV | 17 Jul 2026 | 12.54 | 12.54 | 11.80 | 12.21 | -2.63% |
| CANF Can-Fite BioPharma Ltd. | TLV | 17 Jul 2026 | 5.01 | 5.50 | 4.80 | 4.86 | -3.05% |
| CBI Clal Biotechnology Industries Ltd. | TLV | 17 Jul 2026 | 0.27 | 0.28 | 0.26 | 0.26 | -3.32% |
| BONS Bonus BioGroup Ltd. | TLV | 17 Jul 2026 | 0.29 | 0.30 | 0.26 | 0.28 | -3.45% |
| CGEN Compugen Ltd. | TLV | 17 Jul 2026 | 7.45 | 7.45 | 6.64 | 7.15 | -4.13% |
| MTLF Matricelf Ltd | TLV | 17 Jul 2026 | 2.73 | 2.73 | 2.57 | 2.61 | -4.36% |
| LCTX Lineage Cell Therapeutics, Inc. | TLV | 17 Jul 2026 | 4.09 | 4.09 | 3.50 | 3.76 | -8.05% |